FDA Warning Letter — Jasvil Pharmacy

Case 686742 — FEI 3007007476

The FDA took a Warning Letter action against Jasvil Pharmacy on Jun 18, 2024 (Orange, NJ). The action was issued by CTP and concerns tobacco products.

Action details

Facility
Jasvil Pharmacy
Date
Jun 18, 2024
Fiscal Year
2024
Product Type
Tobacco
Center
CTP
Location
Orange, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.